3D Printed Drug Market Report 2032: Complete Analysis of Additive Manufacturing in Pharmaceuticals, Personalized Dosage Innovation, and Commercialization Opportunities Across 10 Major Markets
7 regulatory shifts accelerating pharmaceutical 3D printing adoption in 2026 The FDA's Center for Drug Evaluation and Research has issued three new guidance documents in Q1 2026 specifically addressing additive manufacturing quality metrics, signaling a decisive pivot toward standardized oversight for personalized therapeutics. This regulatory clarity arrives as European Medicines...
0 التعليقات 0 المشاركات 34 مشاهدة 0 معاينة